Mesoridazine versus chlorpromazine in acute schizophrenia: a double-blind investigation.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D001290:Attitude; D002746:Chlorpromazine / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005260:Female; D006760:Hospitalization; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008653:Mesoridazine / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D009043:Motor Activity; D011569:Psychiatric Status Rating Scales; D012075:Remission, Spontaneous; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D013997:Time Factors
D008653:Mesoridazine; D002746:Chlorpromazine